Literature DB >> 9090347

Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.

M FitzGerald1, K M Malone, S Li, W M Harrison, P A McBride, J Endicott, T Cooper, J J Mann.   

Abstract

OBJECTIVE: Indirect evidence suggests that abnormalities in serotonergic function may be involved in the pathogenesis of premenstrual dysphoric disorder. The goal of this study was to test the hypothesis of serotonergic deficiency in premenstrual dysphoric disorder by measuring the prolactin response to fenfluramine.
METHOD: The authors administered the serotonin-releasing drug dl-fenfluramine in a placebo-controlled protocol to nine women with premenstrual dysphoric disorder and 11 healthy female volunteers in the luteal phase of the menstrual cycle.
RESULTS: Compared to the normal subjects, the women with premenstrual dysphoric disorder had a significantly blunted prolactin response to fenfluramine.
CONCLUSIONS: Premenstrual dysphoric disorder appears to be associated with serotonergic deficiency.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9090347     DOI： 10.1176/ajp.154.4.556

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  10 in total

1.  Neurobiology of stress-induced reproductive dysfunction in female macaques.

Authors:  Cynthia L Bethea; Maria Luisa Centeno; Judy L Cameron
Journal:  Mol Neurobiol       Date:  2008-10-18       Impact factor: 5.590

Review 2.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 3.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.

Authors:  Y Inoue; T Terao; N Iwata; K Okamoto; H Kojima; T Okamoto; R Yoshimura; J Nakamura
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

Review 5.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

6.  Premenstrual Dysphoric Disorder: Recognition and Treatment.

Authors:  Ellen W. Freeman; Steven J. Sondheimer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-02

7.  Premenstrual syndrome.

Authors:  Kimberly Ann Yonkers; P M Shaughn O'Brien; Elias Eriksson
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

Review 8.  Current management of premenstrual syndrome and premenstrual dysphoric disorder.

Authors:  L Born; M Steiner
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 8.081

9.  Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Authors:  Ellen W Freeman
Journal:  Dialogues Clin Neurosci       Date:  2002-06       Impact factor: 5.986

10.  Premenstrual dysphoria and luteal stress in dominant-social-status female macaques.

Authors:  Mingqi Qiao; Qitao Zhao; Sheng Wei; Huiyun Zhang; Haijun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-28       Impact factor: 2.629
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.